The prevalence of comorbidities in Irritable Bowel Syndrome requires a comprehensive clinical approach

Authors

DOI:

https://doi.org/10.22516/25007440.1397

Keywords:

Irritable bowel syndrome

Downloads

Download data is not yet available.

Author Biography

David Benigno Páramo Hernández, GutMédica Instituto de Salud Digestiva

Gastroenterologist and Clinical Epidemiologist. GutMédica, Instituto de salud digestiva. Editor, Colombian Journal of Gastroenterology. Bogotá, Colombia.

References

Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation global study. Gastroenterology. 2021;160(1):99-114.e3. https://doi.org/10.1053/j.gastro.2020.04.014

Páramo Hernández DB, Pineda Ovalle LF, Moya Valenzuela LM, Concha Mejía A. Trastornos de la interacción cerebro-intestino (trastornos funcionales digestivos), racionalidad para el uso de la neuromodulación. Rev Colomb Gastroenterol. 2023;38(2):180-7. https://doi.org/10.22516/25007440.997

Saade Cleves N, Rosselli D. Comorbilidades del síndrome de intestino irritable en Colombia: análisis de datos del Ministerio de Salud. Rev Colomb Gastroenterol. 2025;40(2):145-152. https://doi.org/10.22516/25007440.1289

Drossman DA, Hasler WL. Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology. 2016;150(6):1257-61. https://doi.org/10.1053/j.gastro.2016.03.035

Drossman DA, Tack J, Ford AC, Szigethy E, Törnblom H, van Oudenhove L. Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut-Brain Interaction): A Rome Foundation Working Team Report. Gastroenterology. 2018;154(4):1140-1171.e1. https://doi.org/10.1053/j.gastro.2017.11.279

Drossman DA. Abuse, trauma, and GI illness: is there a link? Am J Gastroenterol. 2011;106(1):14-25. https://doi.org/10.1038/ajg.2010.453

Zamani M, Alizadeh-Tabari S, Zamani V. Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2019;50(2):132-143. https://doi.org/10.1111/apt.15325

Arendt-Nielsen L, Morlion B, Perrot S, Dahan A, Dickenson A, Kress HG, et al. Assessment and manifestation of central sensitisation across different chronic pain conditions. Eur J Pain. 2018;22(2):216-241. https://doi.org/10.1002/ejp.1140

Black CJ, Ford AC. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nat Rev Gastroenterol Hepatol. 2020;17(8):473-486. https://doi.org/10.1038/s41575-020-0286-8

Black CJ, Thakur ER, Houghton LA, Quigley EMM, Moayyedi P, Ford AC. Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis. Gut. 2020;69(8):1441-1451. https://doi.org/10.1136/gutjnl-2020-321191

Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, et al. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2021;116(1):17-44. https://doi.org/10.14309/ajg.0000000000001036

Vasant DH, Paine PA, Black CJ, Houghton LA, Everitt HA, Corsetti M, et al. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut. 2021;70(7):1214-1240. https://doi.org/10.1136/gutjnl-2021-324598

Published

2025-07-04

How to Cite

Páramo Hernández, D. B. (2025). The prevalence of comorbidities in Irritable Bowel Syndrome requires a comprehensive clinical approach. Revista Colombiana De Gastroenterología, 40(2), 143–144. https://doi.org/10.22516/25007440.1397

Issue

Section

Editorial